The primary goal of the X-ray Crystallography Core Facility is to provide access to state-of-the-art hardware, software and expertise to Cancer Center laboratories that use X-ray crystallography as a tool to address questions in their research programs. The Core provides and maintains In-house equipment and computational resources for data collection, processing and structure determination, implements a wide range of crystallographic and structure analysis software packages, participates in multi-institutional consortia for long-term regular access to synchrotron beamlines, and provides training and technical assistance to users of both the in-house and remote facilities. In addition, the Core Head collaborates with non-structural MSKCC groups on macromolecular crystallization and structure-determination projects, and also provides modeling expertise and guidance to those laboratories that can benefit from the use of available structures in the design and interpretation of experiments. Understanding the biological processes involved in tumorigenesis has increasingly benefitted from structural investigations that provide key functional and mechanistic Insights, as well as atomic-level details important for drug discovery. Many of the questions require the structure determination of large proteins, assemblies and macromolecular machines. Advances in protein expression technologies and nano-liter crystallization robots are making it possible to obtain hitherto inaccessible crystals. However, crystals of such complexes often present major experimental challenges due to small crystal size, large unit cells, poor order and limited diffraction. The X-ray Core alms to help address these limitations for MSKCC investigators by providing the latest generation in-house X-ray diffraction systems, by testing and implementing new methods, tools and software and disseminating the latest improvements, and by participating in multi-institutional consortia that not only build and operate synchrotron beamlines, but also carry out technology research and development that push the envelope of beamline capabilities. The X-Ray Crystallography Core has supported 8 investigators in the past year. During the past grant period the Core has contributed to 115 publications of researchers from 3 programs.

Public Health Relevance

Understanding the biological processes involved in tumorigenesis requires the understanding of the underlying structures of relevant proteins, genes and enzymes. The X-Ray Crystallography core provides services to MSKCC investigators interested in structure-function determinations.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA008748-48
Application #
8933521
Study Section
Subcommittee G - Education (NCI)
Program Officer
Shafik, Hasnaa
Project Start
2014-01-01
Project End
2018-12-31
Budget Start
2014-01-01
Budget End
2014-12-31
Support Year
48
Fiscal Year
2014
Total Cost
$271,886
Indirect Cost
$118,883
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Chan, Timothy A; Yarchoan, Mark; Jaffee, Elizabeth et al. (2018) Development of Tumor Mutation Burden as an Immunotherapy Biomarker: Utility for the Oncology Clinic. Ann Oncol :
Owen, Dwight; Chaft, Jamie E (2018) Immunotherapy in surgically resectable non-small cell lung cancer. J Thorac Dis 10:S404-S411
Gill, Samuel C; Lim, Nathan M; Grinaway, Patrick B et al. (2018) Binding Modes of Ligands Using Enhanced Sampling (BLUES): Rapid Decorrelation of Ligand Binding Modes via Nonequilibrium Candidate Monte Carlo. J Phys Chem B 122:5579-5598
Vorkas, Charles Kyriakos; Wipperman, Matthew F; Li, Kelin et al. (2018) Mucosal-associated invariant and ?? T cell subsets respond to initial Mycobacterium tuberculosis infection. JCI Insight 3:
Li, Xiang; Li, Tianfang; Yorke, Ellen et al. (2018) Effects of irregular respiratory motion on the positioning accuracy of moving target with free breathing cone-beam computerized tomography. Int J Med Phys Clin Eng Radiat Oncol 7:173-183
Jain, Devanshi; Puno, M Rhyan; Meydan, Cem et al. (2018) ketu mutant mice uncover an essential meiotic function for the ancient RNA helicase YTHDC2. Elife 7:
Laird, James; Lok, Benjamin; Siu, Chun et al. (2018) Impact of an In Situ Component on Outcome After In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy. Ann Surg Oncol 25:154-163
Leeman, Jonathan E; McBride, Sean M; Spielsinger, Daniel et al. (2018) Head and neck cancers associated with exposure to the September 11, 2001 World Trade Center terrorist attacks. Int J Cancer 142:2485-2490
Reiner, Anne S; Sisti, Julia; John, Esther M et al. (2018) Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study. J Clin Oncol 36:1513-1520
Bhatia, Ankush; Ulaner, Gary; Rampal, Raajit et al. (2018) Single-agent dabrafenib for BRAFV600E-mutated histiocytosis. Haematologica 103:e177-e180

Showing the most recent 10 out of 8799 publications